Boorstein R J, Chiu L N, Teebor G W
Department of Pathology, New York University Medical Center, New York 10016.
Mol Cell Biol. 1992 Dec;12(12):5536-40. doi: 10.1128/mcb.12.12.5536-5540.1992.
We isolated a mutant mammalian cell line lacking activity for the DNA repair enzyme 5-hydroxymethyluracil-DNA glycosylase (HmUra-DNA glycosylase). The mutant was isolated through its resistance to the thymidine analog 5-hydroxymethyl-2'-deoxyuridine (HmdUrd). The mutant incorporates HmdUrd into DNA to the same extent as the parent line but, lacking the repair enzyme, does not remove it. The phenotype of the mutant demonstrates that the toxicity of HmdUrd does not result from substitution of thymine in DNA by HmUra but rather from the removal via base excision of large numbers of HmUra residues in DNA. This finding elucidates a novel mechanism of toxicity for a xenobiotic nucleoside. Furthermore, the isolation of this line supports our hypothesis that the enzymatic repairability of HmUra derives not from its formation opposite adenine via the oxidation of thymine, but rather from its formation opposite guanine as a product of the oxidation and subsequent deamination of 5-methylcytosine.
我们分离出了一种缺乏DNA修复酶5-羟甲基尿嘧啶-DNA糖基化酶(HmUra-DNA糖基化酶)活性的突变哺乳动物细胞系。该突变体是通过其对胸腺嘧啶类似物5-羟甲基-2'-脱氧尿苷(HmdUrd)的抗性分离得到的。该突变体将HmdUrd掺入DNA的程度与亲本系相同,但由于缺乏修复酶,无法将其去除。该突变体的表型表明,HmdUrd的毒性并非源于DNA中胸腺嘧啶被HmUra取代,而是源于通过碱基切除去除DNA中大量的HmUra残基。这一发现阐明了一种异源生物核苷的新毒性机制。此外,该细胞系的分离支持了我们的假设,即HmUra的酶促可修复性并非源于其通过胸腺嘧啶氧化与腺嘌呤配对形成,而是源于其作为5-甲基胞嘧啶氧化和随后脱氨的产物与鸟嘌呤配对形成。